Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...

A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...

New peer-reviewed research demonstrates breakthrough in early detection of adverse pregnancy outcomes for Medicaid patients, achieving 89% accuracy while eliminating racial bias ...

PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts (TMCI), Inc. , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Arash Yavari - Imbria Pharmaceuticals, Inc. Welcome to Medicenna Therapeutics KOL Webinar. [Operator Instructions] As a reminder, this conference call is being recorded. If you have any objections, ...

Ruxolitinib demonstrated sustained efficacy and improved quality of life in myelofibrosis patients in a real-world setting. The JAKoMo study reported fewer adverse events than clinical trials, ...

Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced positive topline results from its randomized, ...